{
	"dataType": "CVE_RECORD",
	"dataVersion": "5.0",
	"cveMetadata": {
		"cveId": "CVE-2015-3954",
		"assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
		"assignerShortName": "icscert",
		"state": "PUBLISHED",
		"datePublished": "2019-03-25T16:12:01",
		"dateUpdated": "2019-03-25T16:12:01",
		"dateReserved": "2015-05-12T00:00:00"
	},
	"containers": {
		"cna": {
			"providerMetadata": {
				"orgID": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
				"shortName": "icscert",
				"dateUpdated": "2019-03-25T16:12:01"
			},
			"descriptions": [
				{
					"lang": "en",
					"value": "Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue."
				}
			],
			"affected": [
				{
					"vendor": "Hospira",
					"product": "Plum A+ Infusion System",
					"versions": [
						{
							"status": "affected",
							"version": "<= 13.4"
						}
					]
				},
				{
					"vendor": "Hospira",
					"product": "Plum A+3 Infusion System",
					"versions": [
						{
							"status": "affected",
							"version": "<= 13.6"
						}
					]
				},
				{
					"vendor": "Hospira",
					"product": "Symbiq Infusion System",
					"versions": [
						{
							"status": "affected",
							"version": "<= 3.13"
						}
					]
				}
			],
			"problemTypes": [
				{
					"descriptions": [
						{
							"type": "CWE",
							"lang": "en",
							"description": "Improper authorization CWE-285",
							"cweId": "CWE-285"
						}
					]
				}
			],
			"references": [
				{
					"tags": [
						"x_refsource_MISC"
					],
					"url": "https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01"
				}
			],
			"datePublic": "2015-06-10T00:00:00",
			"x_legacyV4Record": {
				"CVE_data_meta": {
					"ASSIGNER": "ics-cert@hq.dhs.gov",
					"ID": "CVE-2015-3954",
					"STATE": "PUBLIC"
				},
				"affects": {
					"vendor": {
						"vendor_data": [
							{
								"product": {
									"product_data": [
										{
											"product_name": "Plum A+ Infusion System",
											"version": {
												"version_data": [
													{
														"version_value": "<= 13.4"
													}
												]
											}
										},
										{
											"product_name": "Plum A+3 Infusion System",
											"version": {
												"version_data": [
													{
														"version_value": "<= 13.6"
													}
												]
											}
										},
										{
											"product_name": "Symbiq Infusion System",
											"version": {
												"version_data": [
													{
														"version_value": "<= 3.13"
													}
												]
											}
										}
									]
								},
								"vendor_name": "Hospira"
							}
						]
					}
				},
				"data_format": "MITRE",
				"data_type": "CVE",
				"data_version": "4.0",
				"description": {
					"description_data": [
						{
							"lang": "eng",
							"value": "Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue."
						}
					]
				},
				"problemtype": {
					"problemtype_data": [
						{
							"description": [
								{
									"lang": "eng",
									"value": "Improper authorization CWE-285"
								}
							]
						}
					]
				},
				"references": {
					"reference_data": [
						{
							"name": "https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01",
							"refsource": "MISC",
							"url": "https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01"
						}
					]
				}
			}
		}
	}
}
